FTWA
DGX icon

Fifth Third Wealth Advisors’s Quest Diagnostics DGX Stock Holding History

Fifth Third Wealth Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$756K Buy
+3,569
New +$700K 0.02% 364
2025
Q4 		– Sell
-1,103
Closed -$210K – 805
2025
Q3 		$210K Buy
+1,103
New +$196K 0.01% 726

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BCAM
Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Fifth Third Wealth Advisors's DGX Position: Q2 2026 in Review

Fifth Third Wealth Advisors opened a new position in Quest Diagnostics (DGX) in Q2 2026: 3,569 shares worth $756K. The stake represents 0.02% of the portfolio and ranks #364 among its holdings. This is a return to the name: Fifth Third Wealth Advisors previously reported a position in DGX as recently as Q3 2025.

Fifth Third Wealth Advisors first reported a position in DGX in Q3 2025 and has held it in 2 quarters since. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Fifth Third Wealth Advisors held 3,569 shares of Quest Diagnostics worth $756K as of Q2 2026.
  • Quest Diagnostics was a new Fifth Third Wealth Advisors position in Q2 2026.
  • Quest Diagnostics made up 0.02% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #364 holding.
  • Fifth Third Wealth Advisors first reported a position in Quest Diagnostics in Q3 2025 and has held it in 2 quarters since.
  • 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.